TOPIC

Biomedicine: Industry Trends

Related Topics:
Biomedicine: Companies
Biomedicine: Policy
Biomedicine: Science
Biomedicine: Industry Trends
Biomedicine: Geopolitics
Biomedicine: Industry Trends
Learn about China’s biomedical breakthroughs, from cutting-edge pharmaceuticals to life-saving research, driving global health innovation.
Gina Jiang is managing director of the Hong Kong Institute of Biotechnology. Photo: TMT
Cancer

Groundbreaking cancer therapies are the goal for this biotech innovator

PostMag talks to 5 women innovators at the top of their game and pushing the boundaries of scientific discovery: here we meet Gina Jiang, managing director of the Hong Kong Institute of Biotechnology.

Biomedicine: Companies

Hong Kong biotech start-up Alephoson eyes global trial for eye-drug delivery

New medical drugs

ClouDr shares rise on DeepSeek integration with medical AI platform

videocam
Biomedicine: Companies

Chinese biotech firms cash in on promising drug discoveries via licensing

China has 4,804 new drug candidates under development, second only to the US at 5,268, according to data provider PharmCube.

videocam
The value of Chinese biotech development deals, mostly out-licensing, rose 68 per cent year on year in the first nine months of last year to US$36.6 billion. Photo: Shutterstock
Artificial intelligence

AI-driven drug discovery aided by Greater Bay Area integration, firm says

XtalPi says AI is reducing drug discovery times to two years from four.

videocam
Artificial intelligence

China’s tech push: Shanghai aims to be global medical AI hub by 2027

Despite US export curbs on advanced chips, China’s financial powerhouse is betting big on medical AI.

Advertisement
Advertisement
Advertisement
Science

China-born biologist Wang Cunyu returns from decades in US to head institute

Wang was recognised by Science magazine in 1996 for his work on cancer cell death.

videocam
43
Wang Cunyu, a member of the US National Academy of Medicine, left China for the US in 1990. He has returned to develop Peking University’s Institute of Advanced Clinical Medicine. Photo: Handout
New medical drugs

Novel drug awaits Hong Kong diabetics suffering from debilitating eye disease

Oculis’ OCS-01 eye drops, currently in phase 3 trials for diabetic macular edema, can be an alternative to injection, CEO says.

videocam
Biomedicine: Companies

China welcomes new US$1 billion Sanofi project in Beijing

Sanofi’s latest capital outlay in China will cover the development of a new insulin plant in the nation’s capital.

SCMP Highlights

Recap | ‘Promising’ steps to HIV vaccine, Trump tariffs threaten profits: 5 biotech stories

Discover breakthroughs in the biotech world, from a potential HIV cure to China’s booming drug market and innovative coronavirus treatments, in some of our latest stories.

A Hong Kong biotech start-up says its first-phase trial of a therapeutic HIV vaccine has shown promising results. Photo: dpa
Biomedicine: Companies

Chinese biotech firms brace for Trump tariffs, US funding bill

Efforts to expand sales of high-value products in China and non-US markets would cushion the blow, analysts say.

A robotic surgical system is displayed during the 2024 China Medical Equipment Conference in southwest China’s Chongqing Municipality on March 29, 2024. Photo: Xinhua
China economy

China No 2 in new drugs on the way as market scale tops US$13 billion

China has already approved nearly thrice the number of innovative drugs than in the 13th five-year plan, Shanghai forum hears.

videocam
10
Hong Kong

Vaccine shows promise in curing HIV, Hong Kong start-up says

‘We may be on the brink of a breakthrough,’ Dr Edward Leong, advisory board chairman of Immuno Cure says.

Health in China

Chinese pharmaceutical companies look abroad for growth markets

Shanghai Henlius struck a deal in Saudi Arabia while XtalPi signed a partnership with Sinar Mas Multiartha in Indonesia.

Fosun’s Shanghai Henlius, Tecent-backed XtalPi ink partnership deals with Asian partners. Photo: Shanghai Henlius
Greater Bay Area

Hong Kong health-tech start-ups create digital wearables for seniors

With a regulatory approach that expands the market for such devices to the Greater Bay Area, local companies see opportunity for growth.

videocam
Senior Hongkongers exercise at Victoria Park in Causeway Bay. Photo: Dickson Lee
Biomedicine: Companies

Hong Kong health tech: private-public alliance advances male HPV testing

Neo-Health Group says its device, developed with a government-backed research institute, will also help test for skin infections and cancers.

Health & Fitness

Ultrasound cancer treatment, supported by Li Ka-shing, gains traction in Asia

Focused ultrasound, backed by Li Ka-shing, is emerging as a non-invasive, commercially viable cancer treatment, attracting significant investments.

videocam
Advertisement
Advertisement
Advertisement
Science

China’s strides in academic research seen to narrow US lead in medical science

Growing momentum in research sets China up as a formidable player in future of global healthcare, according to scientific publishers.

videocam
39
China’s overall research output is slowly overtaking the United States, especially in the field of medicine, according to academic publishers. Photo: Shutterstock
China technology

China eyes sci-tech venture capital to boost industrial upgrade, economic growth

Premier Li Qiang said on Wednesday the development of venture capital is critical to sci-tech innovation, industrial upgrading and the growth of the economy.

China's economic recovery

Will medical tourists be the next to benefit from China’s visa-free push?

China is not generally considered a go-to option for healthcare and treatments, with the US, South Korea, Japan and Turkey already on the map.

videocam
8
Health & Fitness

Li Ka-shing’s HutchMed sets up first drugs research facility in Hong Kong

Research facility at the Hong Kong Science and Technology Park will conduct drug discovery in collaboration with university medical schools.

A view of Hong Kong Science and Technology Park in Pak Shek Kok. Photo: Winson Wong
Banking & finance

Hong Kong attracts US$832 million in investment from life-science firms

The investments, which will yield 3,200 jobs, come amid government efforts to enhance Hong Kong’s position as an innovation hub in the field.

The Hong Kong government has created funding incentives to support life sciences firms in every stage of their development from basic research to clinical trials, manufacturing, and marketing, official says. Photo: Shutterstock
Banking & finance

Shanghai’s US$13.8 billion fund of funds to boost AI, semiconductor firms

Mainland China’s commercial and financial hub plans to set up a 100 billion yuan (US$13.8 billion) fund of funds focusing on key technology sectors to fire up the local economy.

Shenzhen

Chinese drugs giant, Shenzhen team up to invest in city’s biomedical start-ups

Fosun Pharma will team up with Shenzhen’s government to raise a 5-billion yuan (US$700 million) healthcare fund to invest in start-ups and innovations in cellular biology, genetics and other fields related to biomedicine.

videocam
Science

As China’s economy undergoes ‘structural upgrade’, tech becomes a top priority

That amounts to US$51.5 billion for 2024, with continued expenditure ‘guaranteed’ because of sector’s key role in driving development.

videocam
50
Science and technology has emerged as a priority area for Beijing. Photo: Shutterstock Images
Banking & finance

Big pharma preferred over old favourite biotech firms by foreign investors

Big Chinese pharmaceutical firms with a track record of profits will be key beneficiaries of China reopening, with pre-revenue biotechnology companies falling out of favour, Citigroup says.

videocam
Travellers at the mainland Chinese border in Shenzhen. China reopened its borders for international travel on Sunday and will roll out more pro-growth measures to steady the economy. Photo: Dickson Lee
Medicine

Hong Kong as genetics hub? First ask China

Without China allowing Hong Kong to use its genetics data, a proposed database centre would be of limited use.

Advertisement
Advertisement
Advertisement
Help preserve 120 years of quality journalism.
SUPPORT NOW
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement